Not sure why some are constantly trying to talk this share down. Especially when we have had good news on 3 fronts, purchase of N Act D, dual combo patent and Sanofi results. Company is building a good foundation and a great investment case. Furthermore not just a one trick pony. Wish all holders success. I have just topped up.
Imo Sanofi results are great indications that TZLS 501s drug will be successful and possibly fast tracked, furthermore company building support by purchase of NP act D. Further patent rns. In my view company is building a good foundation .
RE: standout quotes from the interview24 Apr 2020 01:48
I took the same meaning, results are good enough to move to manufacture, furthermore you would also only move to manufacture if you have had the nod from regulators/approvals. Also great research re interferon effects on covid.
RE: standout quotes from the interview24 Apr 2020 01:48
I took the same meaning, results are good enough to move to manufacture, furthermore you would also only move to manufacture if you have had the nod from regulators/approvals. Also great research re interferon effects on covid.
You do not start the manufacturing process unless you have positive results but also a nod from regulators that they will guarantee approval. Anyone selling today will be sorry tomorrow
The price action suggests they were worked during the day and imo were buys. Furthermore no similar action in the USA. However whether there is any follow through tomorrow is anyone's guess. Let's hope
Also 2 x 50000 buys nothing to be sniffed at. 2 x 290000 buys probably reason for buys. Today was probably bottom. Fully funded for future. Would like to see blue tomorrow also. Gla
They also did a deal with Alder biopharmaceutical to develop similar drug in Nov 2019 worth $200 million to develop ald518 designed to block pro inflammatory molecules interleukin 6. This could be huge
With news due on many fronts and more importantly positive results from trials due imminently. Company is fully funded and when positive results land they have the funds to manufacture and distribute. Upwards is the only direction. Patience required 60-77p , will seem cheap. Remember initial target 120p
There is obviously a similarity to another share, similar treatment using similar delivery method. I own this share due to this similarity and the other. I have done quite a bit of research over the years and both companies were developing their drugs to help respiratory function. Both drugs help the lungs recover from a severe respiratory virus and improves lung function. These unbeknown to the company during development are the best possible treatment solution for covid19. Both companies have reacted to a steep rise in their share price by undertaking a dual fundraise initial and secondary. The fundraise protects the future. After the initial fund raise the other company also dipped and recovered. Both SP have behaved in similar fashion. You will see lower lows and higher highs. Expect recovery here and positive news. Next news I expect is urgent testing in USA. Similar testing in China have provided positive results. This in my believe is a contender in the fight to save lives in this pandemic. Gla.
John totally agree not even at phase 1 or testing. Sng so much further along. Tils has been pump and dump before. Sng could easily patent and rns it. Today's rns was just that they patented there drug. After reading thru all research over the years I am in full belief that sng001 will work for covid